← Back to catalogue

SurFuse

FDA UDI

Class II (US FDA UDI)

by Hans Biomed Corporation

Identity

Trade Name
SurFuse FDA UDI
Generic Name
Bone matrix implant, human-derived FDA UDI
Model / Reference
SP3 FDA UDI

Identifiers

Primary DI / UDI-DI
08809204339112 FDA UDI
FDA Product Code
MBP FDA UDI
MQV FDA UDI
NUN FDA UDI
GMDN Term
Bone matrix implant, human-derived FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
888.3045 FDA UDI
872.3930 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

Yes

FDA UDI

Implantable

Yes

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

Yes

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Bone matrix implant, human-derived

Hans Biomed Corp.'s SurFuse bone matrix implant is a bioabsorbable, osteoconductive device designed to fill bony voids or gaps caused by trauma or surgery. Made from human-derived demineralized bone matrix (DBM), it stimulates new bone growth and has demonstrated at least potential osteoinductivity.

Similar devices

Also classified as Bone matrix implant, human-derived.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 3afc22fe-e1ee-4bc8-9ed0-acb0de738d28 32 fields · synced Jul 28, 2026